Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 6
1982 2
1983 1
1985 4
1986 3
1987 1
1988 3
1989 2
1990 6
1991 2
1992 3
1993 4
1994 5
1995 3
1996 2
1997 2
1998 3
1999 5
2000 3
2001 2
2002 5
2004 2
2005 4
2007 3
2008 4
2009 4
2010 3
2011 9
2012 7
2013 5
2014 6
2015 4
2016 3
2017 6
2018 6
2019 2
2020 3
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Nanomedicine for the Treatment of Alzheimer's Disease.
Formicola B, Cox A, Dal Magro R, Masserini M, Re F. Formicola B, et al. Among authors: masserini m. J Biomed Nanotechnol. 2019 Oct 1;15(10):1997-2024. doi: 10.1166/jbn.2019.2837. J Biomed Nanotechnol. 2019. PMID: 31462368 Review.
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.
Re F, Giorgetti S, Biondi B, Scapin S, Mantegazza F, Cassina V, Sesana SM, Rizzi L, Eberini I, Palazzolo L, Beeg M, Gobbi M, Sardina M, Masserini M. Re F, et al. Among authors: masserini m. Ann Med. 2023 Dec;55(1):2205659. doi: 10.1080/07853890.2023.2205659. Ann Med. 2023. PMID: 37143345 Free PMC article.
Nanotechnology for neurodegenerative disorders.
Re F, Gregori M, Masserini M. Re F, et al. Among authors: masserini m. Nanomedicine. 2012 Sep;8 Suppl 1:S51-8. doi: 10.1016/j.nano.2012.05.007. Epub 2012 May 26. Nanomedicine. 2012. PMID: 22640910 Review.
Nanotechnology for neurodegenerative disorders.
Re F, Gregori M, Masserini M. Re F, et al. Among authors: masserini m. Maturitas. 2012 Sep;73(1):45-51. doi: 10.1016/j.maturitas.2011.12.015. Epub 2012 Jan 17. Maturitas. 2012. PMID: 22261367 Review.
Nanoparticles for brain drug delivery.
Masserini M. Masserini M. ISRN Biochem. 2013 May 21;2013:238428. doi: 10.1155/2013/238428. eCollection 2013. ISRN Biochem. 2013. PMID: 25937958 Free PMC article. Review.
Proteomics of plasma membrane microdomains.
Raimondo F, Ceppi P, Guidi K, Masserini M, Foletti C, Pitto M. Raimondo F, et al. Among authors: masserini m. Expert Rev Proteomics. 2005 Oct;2(5):793-807. doi: 10.1586/14789450.2.5.793. Expert Rev Proteomics. 2005. PMID: 16209657 Review.
Pin1: a new outlook in Alzheimer's disease.
Lonati E, Masserini M, Bulbarelli A. Lonati E, et al. Among authors: masserini m. Curr Alzheimer Res. 2011 Sep;8(6):615-22. doi: 10.2174/156720511796717140. Curr Alzheimer Res. 2011. PMID: 21605045 Review.
GPI-anchored proteins and lipid rafts.
Sangiorgio V, Pitto M, Palestini P, Masserini M. Sangiorgio V, et al. Among authors: masserini m. Ital J Biochem. 2004 Jul;53(2):98-111. Ital J Biochem. 2004. PMID: 15646015 Review.
Nanomedicine for the treatment of Alzheimer's disease.
Gregori M, Masserini M, Mancini S. Gregori M, et al. Among authors: masserini m. Nanomedicine (Lond). 2015;10(7):1203-18. doi: 10.2217/nnm.14.206. Nanomedicine (Lond). 2015. PMID: 25929574 Review.
138 results